Results of an Intervention in an Academic Internal Medicine Clinic to Continue, Step-Down, or Discontinue Proton Pump Inhibitor Therapy Related to a Tennessee Medicaid Formulary Change

BACKGROUND: In July 2005, the State of Tennessee Medicaid Program (TennCare) announced formulary changes for proton pump inhibitors (PPIs) to be implemented in August 2005. Prior to these changes, pantoprazole was the only preferred PPI, and there were no restrictions to its use. The revised formula...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramser, Kristie L., Sprabery, Laura R., Hamann, Gale L., George, Christa M., Will, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2009
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437514/
https://www.ncbi.nlm.nih.gov/pubmed/19422274
http://dx.doi.org/10.18553/jmcp.2009.15.4.344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437514/
https://www.ncbi.nlm.nih.gov/pubmed/19422274
http://dx.doi.org/10.18553/jmcp.2009.15.4.344

Ejemplares similares